These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway. Bouma EM; van de Pol DPI; Sanders ID; Rodenhuis-Zybert IA; Smit JM J Virol; 2020 Jun; 94(13):. PubMed ID: 32321803 [TBL] [Abstract][Full Text] [Related]
6. Suramin Inhibits Chikungunya Virus Entry and Transmission. Ho YJ; Wang YM; Lu JW; Wu TY; Lin LI; Kuo SC; Lin CC PLoS One; 2015; 10(7):e0133511. PubMed ID: 26208101 [TBL] [Abstract][Full Text] [Related]
7. Suramin inhibits chikungunya virus replication through multiple mechanisms. Albulescu IC; van Hoolwerff M; Wolters LA; Bottaro E; Nastruzzi C; Yang SC; Tsay SC; Hwu JR; Snijder EJ; van Hemert MJ Antiviral Res; 2015 Sep; 121():39-46. PubMed ID: 26112648 [TBL] [Abstract][Full Text] [Related]
8. Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles. Albulescu IC; Kovacikova K; Tas A; Snijder EJ; van Hemert MJ Antiviral Res; 2017 Jul; 143():230-236. PubMed ID: 28461070 [TBL] [Abstract][Full Text] [Related]
9. Emerging Chikungunya Virus Variants at the E1-E1 Interglycoprotein Spike Interface Impact Virus Attachment and Inflammation. Rangel MV; McAllister N; Dancel-Manning K; Noval MG; Silva LA; Stapleford KA J Virol; 2022 Feb; 96(4):e0158621. PubMed ID: 34935436 [TBL] [Abstract][Full Text] [Related]
10. Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection. Oo A; Rausalu K; Merits A; Higgs S; Vanlandingham D; Bakar SA; Zandi K Antiviral Res; 2018 Feb; 150():101-111. PubMed ID: 29269135 [TBL] [Abstract][Full Text] [Related]
11. 4'-Fluorouridine inhibits alphavirus replication and infection Yin P; May NA; Lello LS; Fayed A; Parks MG; Drobish AM; Wang S; Andrews M; Sticher Z; Kolykhalov AA; Natchus MG; Painter GR; Merits A; Kielian M; Morrison TE mBio; 2024 Jun; 15(6):e0042024. PubMed ID: 38700353 [TBL] [Abstract][Full Text] [Related]
12. Changes in the chikungunya virus E1 glycoprotein domain II and hinge influence E2 conformation, infectivity, and virus-receptor interactions. Thannickal SA; Battini L; Spector SN; Noval MG; Álvarez DE; Stapleford KA J Virol; 2024 Jul; 98(7):e0067924. PubMed ID: 38842335 [TBL] [Abstract][Full Text] [Related]
13. Structural basis of Chikungunya virus inhibition by monoclonal antibodies. Zhou QF; Fox JM; Earnest JT; Ng TS; Kim AS; Fibriansah G; Kostyuchenko VA; Shi J; Shu B; Diamond MS; Lok SM Proc Natl Acad Sci U S A; 2020 Nov; 117(44):27637-27645. PubMed ID: 33087569 [TBL] [Abstract][Full Text] [Related]
15. A combination of doxycycline and ribavirin alleviated chikungunya infection. Rothan HA; Bahrani H; Mohamed Z; Teoh TC; Shankar EM; Rahman NA; Yusof R PLoS One; 2015; 10(5):e0126360. PubMed ID: 25970853 [TBL] [Abstract][Full Text] [Related]
16. Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics. Davuluri KS; Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D Front Cell Infect Microbiol; 2024; 14():1335189. PubMed ID: 38895735 [TBL] [Abstract][Full Text] [Related]
18. Tomatidine, a natural steroidal alkaloid shows antiviral activity towards chikungunya virus in vitro. Troost B; Mulder LM; Diosa-Toro M; van de Pol D; Rodenhuis-Zybert IA; Smit JM Sci Rep; 2020 Apr; 10(1):6364. PubMed ID: 32286447 [TBL] [Abstract][Full Text] [Related]
19. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220 [TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel antiviral agent targeting the nonstructural protein 4 (nsP4) of chikungunya virus. Wada Y; Orba Y; Sasaki M; Kobayashi S; Carr MJ; Nobori H; Sato A; Hall WW; Sawa H Virology; 2017 May; 505():102-112. PubMed ID: 28236746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]